Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07603258 · ClinicalTrials.gov registry record · Phase 2

Access-H20: Sensor-driven Smart Faucet Related Study

A Phase 2 study, sponsored by Old Dominion University.

Completed
Registry status
Phase 2
Development phase
23
Enrollment target

NCT07603258 is a Phase 2 study that has completed, run by Old Dominion University. The registered enrollment target is 23 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07603258, a Phase 2 study, has completed, sponsored by Old Dominion University.

COMPLETED
Registry status
Phase 2
Development phase
23 participants
Enrollment target

Study Summary

The objective of the SBIR Phase II study is to evaluate the updated Access-H2O™ system, a sensor-driven smart faucet developed during the Phase I SBIR project, to enhance independent drinking and grooming among individuals with spinal cord injury (SCI) in both clinical and home settings. SCI significantly impairs functional independence and the ability to perform activities of daily living (ADLs), with greater loss of function associated with higher and more complete injuries. In particular, individuals with injuries above the C5-C7 level often experience substantial upper extremity impairment, limiting their ability to use their arms and hands for essential tasks such as eating, drinking, and grooming. Access to water is therefore critical for supporting independence and facilitating the successful completion of ADLs in this population. The commercialization of a smart faucet system capable of automatically delivering water at target temperature, flow rate, and nozzle settings tailored to specific ADLs has the potential to substantially improve independence and quality of life for individuals with SCI. The Access-H2O™ faucet was developed and tested during the SBIR Phase I project in 2024 and was subsequently upgraded and refined based on Phase I findings. Participants with SCI, along with control participants, were recruited to evaluate the usability of the enhanced faucet system in both clinical and in-home settings. The updated system incorporates voice, motion, and remote-control interfaces to regulate water flow and temperature for ADLs, including drinking, grooming, and washing.

Interventions

  • DEVICE Water Faucet

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2024-02-01
Est. Completion 2024-08-31
Phase Phase 2

Sponsor

Old Dominion University

23 total trials

What the Registry Record Tells You About NCT07603258

The ClinicalTrials.gov registry entry for NCT07603258 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Old Dominion University, which has 23 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Water Faucet is the first listed.

NCT07603258 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07603258 about?

NCT07603258 is a clinical study titled "Access-H20: Sensor-driven Smart Faucet Related Study". The objective of the SBIR Phase II study is to evaluate the updated Access-H2O™ system, a sensor-driven smart faucet developed during the Phase I SBIR project, to enhance independent drinking and grooming among individuals with spinal cord injury (SCI) in both clinical and home settings. SCI signifi...

What is the current status of trial NCT07603258?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 23 participants. The study started on 2024-02-01. Estimated completion is 2024-08-31.

What interventions are being tested in trial NCT07603258?

The interventions under investigation include: Water Faucet (DEVICE).

Who is sponsoring clinical trial NCT07603258?

This trial is sponsored by Old Dominion University, which has 23 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.